The Helsinki-based company develops AI-powered software that helps pathologists identify cancer more accurately in images of tissue samples. Pathology is central to cancer diagnosis and treatment, but the field faces a global shortage of resources while sample volumes keep growing. According to Aiforia, its solution makes pathologists’ work more efficient and gives patients more consistent, accurate, and faster diagnoses, wherever they live.

The winners were announced on October 8 at the Atea Focus event at the Helsinki Expo and Convention Centre. When selecting Aiforia as a finalist, the jury highlighted the solution’s societal significance and international potential. “Innovation is no longer experimental, but widely used, with credibility brought in particular by the Mayo Clinic in the US,” the jury states.

“We are extremely pleased with this recognition. This win is a great demonstration of our team’s dedication and the high standard of Finnish health tech,” says Jukka Tapaninen, CEO, Aiforia.